U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Guidance, Compliance, & Regulatory Information
  4. Enforcement Activities | FDA
  5. Warning Letters and Notice of Violation Letters to Pharmaceutical Companies
  6. Untitled Letters 2023
  1. Warning Letters and Notice of Violation Letters to Pharmaceutical Companies

Untitled Letters 2023

These letters are supplied by the CDER Freedom of Information Office and only covers Office of Prescription Drug Promotion's untitled letters. The agency may have redacted or edited some of the letters to remove confidential information.

Office of Prescription Drug Promotion Untitled Letter and Promotional Material

Company / Individual Product / Issue Issued Date

Xeris Pharmaceuticals, Inc.

NDA 214133 RECORLEV (levoketoconazole) tablets, oral 6/07/2023
Back to Top